These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 19372864)

  • 1. Treatment interruption in advanced failing patients.
    Staszewski S
    Curr Opin HIV AIDS; 2007 Jan; 2(1):39-45. PubMed ID: 19372864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of selecting resistance mutations during treatment interruption.
    Martinez-Picado J; Wai Yan Tam L
    Curr Opin HIV AIDS; 2007 Jan; 2(1):6-13. PubMed ID: 19372859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment interruption strategies: how great are the risks?
    Paton NI
    Curr Opin Infect Dis; 2008 Feb; 21(1):25-30. PubMed ID: 18192782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological rebound and its consequences during treatment interruption.
    van Lunzen J; Hoffmann C
    Curr Opin HIV AIDS; 2007 Jan; 2(1):1-5. PubMed ID: 19372858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment interruption for convenience, cost cutting and toxicity sparing.
    Nüesch R; Hirschel B
    Curr Opin HIV AIDS; 2007 Jan; 2(1):31-8. PubMed ID: 19372863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment interruption in chronic HIV-1 infection: does it deliver?
    Willberg CB; Nixon DF
    Curr Opin HIV AIDS; 2007 Jan; 2(1):26-30. PubMed ID: 19372862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption.
    Lederman MM; Penn-Nicholson A; Stone SF; Sieg SF; Rodriguez B
    Curr Opin HIV AIDS; 2007 Jan; 2(1):56-61. PubMed ID: 19372866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment interruption to boost specific HIV immunity in acute infection.
    Kaufmann DE; Walker BD
    Curr Opin HIV AIDS; 2007 Jan; 2(1):21-5. PubMed ID: 19372861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Issues in the design of trials comparing management strategies for heavily pretreated patients.
    Phillips AN; Cohen C; Lundgren JD
    Curr Opin HIV AIDS; 2006 Nov; 1(6):476-81. PubMed ID: 19372849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced ovarian cancer: a clinical update on first-line treatment, recurrent disease, and new agents.
    Ozols RF
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 2():S60-73. PubMed ID: 19780247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials for heavily pretreated patients: update in 2006.
    Katlama C; Ghosn J
    Curr Opin HIV AIDS; 2006 Nov; 1(6):495-501. PubMed ID: 19372852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes for therapeutic vaccines trials.
    Taiwo B; Murphy R
    Curr Opin HIV AIDS; 2006 Nov; 1(6):502-6. PubMed ID: 19372853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerotic vascular disease in HIV: it is not just antiretroviral therapy that hurts the heart!
    van Leuven SI; Sankatsing RR; Vermeulen JN; Kastelein JJ; Reiss P; Stroes ES
    Curr Opin HIV AIDS; 2007 Jul; 2(4):324-31. PubMed ID: 19372907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.
    Prescrire Int; 2008 Aug; 17(96):135-7. PubMed ID: 19480091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.
    Castor D; Vlahov D; Hoover DR; Berkman A; Wu YF; Zeller B; Brechtl J; Hammer SM
    J Med Virol; 2009 Aug; 81(8):1323-35. PubMed ID: 19551816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopenia and osteoporosis in HIV: pathogenesis and treatment.
    Chew NS; Doran PP; Powderly WG
    Curr Opin HIV AIDS; 2007 Jul; 2(4):318-23. PubMed ID: 19372906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of maintenance chemotherapy in advanced nonsmall cell lung cancer.
    Jalal SI; Ademuyiwa FO; Hanna NH
    Curr Opin Oncol; 2009 Mar; 21(2):110-5. PubMed ID: 19532011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prevention of heart failure: what is the evidence?
    Dupree CS
    Curr Opin Cardiol; 2009 Mar; 24(2):142-7. PubMed ID: 19532100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET monitoring of therapy response in head and neck squamous cell carcinoma.
    Schöder H; Fury M; Lee N; Kraus D
    J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.